Fairscale Capital »

United Therapeutics Corporation shares owned by Fairscale Capital

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 50 358.36
2024-06-30 $16k 50 328.20

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
iShares S&P NA Tech. Sec. Idx (IGM)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc equity (VOOV)
Apple (AAPL)
Pacer Fds Tr us cash cows 100 (COWZ)
Microsoft Corporation (MSFT)
Invesco Qqq Trust Series 1 (QQQ)
Visa (V)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Schwab Strategic Tr us dividend eq (SCHD)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Facebook Inc cl a (META)

View all positions for Fairscale Capital

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Geode Capital Management
LSV Asset Management
Morgan Stanley
AQR Capital Management
Dimensional Fund Advisors
Hanna Zanoni
Pacer Advisors
Alliancebernstein
Arrowstreet Capital, Limited Partnership
Nuveen Asset Management
Assetmark

View all funds holding United Therapeutics Corporation